PMP 22 Gene

Myelin Biology and Disorders

Volumn 1, Issue , 2004, Pages 547-564

  Suter, Ueli ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903106108     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012439510-7/50074-7     Document Type: Chapter

References (182)

1. Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K.V., Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet 1995, 11:274-280.
2. Adlkofer K., Frei R., Neuberg D.H., Zielasek J., Toyka K.V., Suter U. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci 1997, 17:4662-4671.
3. Adlkofer K., Naef R., Suter U. Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele. J Neurosci Res 1997, 49:671-680.
4. Agostoni E., Gobessi S., Brancolini C., Schneider C. Identification and characterization of a new member of the gas3/PMP22 gene family in C. elegans. Gene 1999, 234:267-274.
5. Attardi L.D., Reczek E.E., Cosmas C., Demicco E.G., McCurrach M.E., Lowe S.W., Jacks T. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 2000, 14:704-718.
6. Ayers M.M., Anderson R.M. Onion bulb neuropathy in the Trembler mouse: A model of hypertrophic interstitial neuropathy (Dejerine-Sottas) in man. Acta Neuropathol 1973, 25:54-70.
7. Baechner D., Liehr T., Hameister H., Altenberger H., Grehl H., Suter U., Rautenstrauss B. Widespread expression of the peripheral myelin protein-22 gene (PMP22) in neural and non-neural tissues during murine development. J Neurosci Res 1995, 42:733-741.
8. Beckmann A., Schroder J.M. Recessive PMP22 mutations: Quantitative and qualitative aspects. Ann Neurol 2000, 48:131-132.
9. Ben-Porath I., Yanuka O., Benvenisty N. The tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity. Mol Cell Biol 1999, 19:3529-3539.
10. Berger P., Young P., Suter U. Molecular cell biology of Charcot-Marie-Tooth disease. Neurogenetics 2002, 4:1-15.
11. Birouk N., Gouider R., Le Guern E., Gugenheim M., Tardieu S., Maisonobe T., Le Forestier N., Agid Y., Brice A., Bouche P. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 1997, 120:813-823.
12. Bissar-Tadmouri N., Parman Y., Boutrand L., Deymeer F., Serdaroglu P., Vandenberghe A., Battaloglu E. Mutational analysis and genotype/phenotype correlation in Turkish Charcot-Marie-Tooth Type 1 and HNPP patients. Clin Genet 2000, 58:396-402.
13. Boerkoel C.F., Takashima H., Garcia C.A., Olney R.K., Johnson J., Berry K., Russo P., Kennedy S., Teebi A.S., Scavina M., et al. Charcot-Marie-Tooth disease and related neuropathies: Mutation distribution and genotype-phenotype correlation. Ann Neurol 2002, 51:190-201.
14. Bogdanov M., Heacock P.N., Dowhan W. A polytopic membrane protein displays a reversible topology dependent on membrane lipid composition. Embo J 2002, 21:2107-2116.
15. Bolin L.M., McNeil T., Lucian L.A., DeVaux B., Franz-Bacon K., Gorman D.M., Zurawski S., Murray R., McClanahan T.K. HNMP-1: A novel hematopoietic and neural membrane protein differentially regulated in neural development and injury. J Neurosci 1997, 17:5493-5502.
16. Bort S., Nelis E., Timmerman V., Sevilla T., Cruz-Martinez A., Martinez F., Millan J.M., Arpa J., Vilchez J.J., Prieto F., et al. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies. Hum Genet 1997, 99:746-754.
17. Bosse F., Brodbeck J., Muller H.W. Post-transcriptional regulation of the peripheral myelin protein gene PMP22/gas3. J Neurosci Res 1999, 55:164-177.
18. Brancolini C., Edomi P., Marzinotto S., Schneider C. Exposure at the cell surface is required for gas3/PMP22 to regulate both cell death and cell spreading: Implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases. Mol Biol Cell 2000, 11:2901-2914.
19. Brancolini C., Marzinotto S., Edomi P., Agostoni E., Fiorentini C., Muller H.W., Schneider C. Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. Mol Biol Cell 1999, 10:2441-2459.
20. Carenini S., Neuberg D., Schachner M., Suter U., Martini R. Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice. Glia 1999, 28:256-264.
21. Ceuterick-de Groote C., De Jonghe P., Timmerman V., Van Goethem G., Lofgren A., Ceulemans B., Van Broeckhoven C., Martin J.J. Infantile demyelinating neuropathy associated with a de novo point mutation on Ser72 in PMP22 and basal lamina onion bulbs in skin biopsy. Pathol Res Pract 2001, 197:193-198.
22. Chance P.F., Abbas N., Lensch M.W., Pentao L., Roa B.B., Patel P.I., Lupski J.R. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet 1994, 3:223-228.
23. Chance P.F., Alderson M.K., Leppig K.A., Lensch M.W., Matsunami N., Smith B., Swanson P.D., Odelberg S.J., Disteche C.M., Bird T.D. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993, 72:143-151.
24. Chen Y., Medvedev A., Ruzanov P., Marvin K.W., Jetten A.M. cDNA cloning, genomic structure, and chromosome mapping of the human epithelial membrane protein CL-20 gene (EMP1), a member of the PMP22 family. Genomics 1997, 41:40-48.
25. Church R.L., Wang J.H. The human lens fiber-cell intrinsic membrane protein MP19 gene: Isolation and sequence analysis. Curr Eye Res 1993, 12:1057-1065.
26. Ciccarelli C., Philipson L., Sorrentino V. Regulation of expression of growth arrest-specific genes in mouse fibroblasts. Mol Cell Biol 1990, 10:1525-1529.
27. Colby J., Nicholson R., Dickson K.M., Orfali W., Naef R., Suter U., Snipes G.J. PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells. Neurobiol Dis 2000, 7:561-573.
28. Cowled P.A., Ciccarelli C., Coccia E., Philipson L., Sorrentino V. Expression of growth arrest-specific (gas) genes in senescent murine cells. Exp Cell Res 1994, 211:197-202.
29. Cruz-Martinez A., Bort S., Arpa J., Duarte J., Palau F. Clinical, genetic and electrophysiological correlation in hereditary neuropathy with liability to pressure palsies with involvement of the PMP22 gene at chromosome 17. Eur J Neurol 1997, 4:274-286.
30. D'Urso D., Ehrhardt P., Muller H.W. Peripheral myelin protein 22 and protein zero: A novel association in peripheral nervous system myelin. J Neurosci 1999, 19:3396-3403.
31. D'Urso D., Muller H.W. Ins and outs of peripheral myelin protein-22: Mapping transmembrane topology and intracellular sorting. J Neurosci Res 1997, 49:551-562.
32. D'Urso D., Prior R., Greiner-Petter R., Gabreels-Festen A.A., Muller H.W. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J Neurosci 1998, 18:731-740.
33. De Leon M., Nahin R.L., Mendoza M.E., Ruda M.A. SR13/PMP-22 expression in rat nervous system, in PC12 cells, and C6 glial cell lines. J Neurosci Res 1994, 38:167-181.
34. De Leon M., Welcher A.A., Suter U., Shooter E.M. Identification of transcriptionally regulated genes after sciatic nerve injury. J Neurosci Res 1991, 29:437-448.
35. Dejerine J., Sottas J. Sur la névrite interstitielle, hypertrophique et progressive de l'enfance. CR Soc Biol 1893, 45:63-96.
36. Desarnaud F., Bidichandani S., Patel P.I., Baulieu E.E., Schumacher M. Glucocorticosteroids stimulate the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. Brain Res 2000, 865:12-16.
37. Desarnaud F., Do Thi A.N., Brown A.M., Lemke G., Suter U., Baulieu E.E., Schumacher M. Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J Neurochem 1998, 71:1765-1768.
38. Dickson K.M., Bergeron J.J., Shames I., Colby J., Nguyen D.T., Chevet E., Thomas D.Y., Snipes G.J. Association of calnexin with mutant peripheral myelin protein-22 ex vivo: A basis for "gain-of-function" ER diseases. Proc Natl Acad Sci USA 2002, 99:9852-9857.
39. Ekici A.B., Park O., Korinthenberg R., Grehl H., Rautenstrauss B. T〉C transition in codon 72 (TCG→CCG), S72P, a putative hotspot in PMP22. Hum Mutat 2001, 17:81.
40. Ekici A.B., Schweitzer D., Park O., Lorek D., Rautenstrauss B., Kruger G., Friedl W., Uhlhaas S., Bathke K., Heuss D., et al. Charcot-Marie-Tooth disease and related peripheral neuropathies: Novel mutations in the peripheral myelin genes connexin 32 (Cx32), peripheral myelin protein 22 (PMP22), and peripheral myelin protein zero (MPZ). Neurogenetics 2000, 3:49-50.
41. Erdem S., Mendell J.R., Sahenk Z. Fate of Schwann cells in CMT1A and HNPP: Evidence for apoptosis. J Neuropathol Exp Neurol 1998, 57:635-642.
42. Erne B., Sansano S., Frank M., Schaeren-Wiemers N. Rafts in adult peripheral nerve myelin contain major structural myelin proteins and myelin and lymphocyte protein (MAL) and CD59 as specific markers. J Neurochem 2002, 82:550-562.
43. Fabbretti E., Edomi P., Brancolini C., Schneider C. Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: Its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev 1995, 9:1846-1856.
44. Fabrizi G.M., Cavallaro T., Taioli F., Orrico D., Morbin M., Simonati A., Rizzuto N. Myelin uncompaction in Charcot-Marie-Tooth neuropathy type 1A with a point mutation of peripheral myelin protein-22. Neurology 1999, 53:846-851.
45. Fields R.D., Stevens B. ATP: An extracellular signaling molecule between neurons and glia. Trends Neurosci 2000, 23:625-633.
46. Fleming J.V., Fontanier N., Harries D.N., Rees W.D. The growth arrest genes gas5, gas6, and CHOP-10 (gadd153) are expressed in the mouse preimplantation embryo. Mol Reprod Dev 1997, 48:310-316.
47. Gabreels-Festen A. Dejerine-Sottas syndrome grown to maturity: Overview of genetic and morphological heterogeneity and follow-up of 25 patients. J Anat 2002, 200:341-356.
48. Gabreels-Festen A.A., Bolhuis P.A., Hoogendijk J.E., Valentijn L.J., Eshuis E.J., Gabreels F.J. Charcot-Marie-Tooth disease type 1A: Morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol 1995, 90:645-649.
49. Gabriel J.M., Erne B., Pareyson D., Sghirlanzoni A., Taroni F., Steck A.J. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies. Neurology 1997, 49:1635-1640.
50. Garcia C.A., Malamut R.E., England J.D., Parry G.S., Liu P., Lupski J.R. Clinical variability in identical twins with Charcot-Marie-Tooth disease type 1A duplication. Neurology 1995, 45:2090-2093.
51. Hagedorn L., Suter U., Sommer L. P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors. Development 1999, 126:3781-3794.
52. Hai M., Bidichandani S.I., Hogan M.E., Patel P.I. Competitive binding of triplex-forming oligonucleotides in the two alternate promoters of the PMP22 gene. Antisense Nucleic Acid Drug Dev 2001, 11:233-246.
53. Hai M., Bidichandani S.I., Patel P.I. Identification of a positive regulatory element in the myelinspecific promoter of the PMP22 gene. J Neurosci Res 2001, 65:508-519.
54. Hammer J.A., O'Shannessy D.J., De Leon M., Gould R., Zand D., Daune G., Quarles R.H. Immunoreactivity of PMP-22, P0, and other 19 to 28 kDa glycoproteins in peripheral nerve myelin of mammals and fish with HNK1 and related antibodies. J Neurochem 1993, 35:546-558.
55. Hanemann C.O., Gabreels-Festen A.A., Stoll G., Muller H.W. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): Normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs. Acta Neuropathol (Berl) 1997, 94:310-315.
56. Hanemann C.O., Rosenbaum C., Kupfer S., Wosch S., Stoegbauer F., Muller H.W. Improved culture methods to expand Schwann cells with altered growth behaviour from CMT1A patients In Process Citation. Glia 1998, 22:89-98.
57. Hanemann C.O., Stoll G., D'Urso D., Fricke W., Martin J.J., Van Broeckhoven C., Mancardi G.L., Bartke I., Muller H.W. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies. J Neurosci Res 1994, 37:654-659.
58. Hanemann C.O., Stoll G., Muller H.W. PMP22 expression in CMT1a neuropathy. Ann Neurol 1995, 37:136.
59. Haney C., Snipes G.J., Shooter E.M., Suter U., Garcia C., Griffin J.W., Trapp B.D. Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A. J Neuropathol Exp Neurol 1996, 55:290-299.
60. Hasse B., Bosse F., Muller H.W. Proteins of peripheral myelin are associated with glycosphingolipid/cholesterol-enriched membranes. J Neurosci Res 2002, 69:227-232.
61. Henry E.W., Cowen J.S., Sidman R.L. Comparison of trembler and trembler-J phenotypes: Varying severity of peripheral hypomyelination. J Neuropathol Exp Neurol 1983, 42:688-706.
62. Hoogendijk J.E., Hensels G.W., Gabreels F.A., Gabreels F.J., Janssen E.A., de J.P., Martin J.J., van B.C., Valentijn L.J., Baas F., et al. De-novo mutation in hereditary motor and sensory neuropathy type I. Lancet 1992, 339:1081-1082.
63. Huehne K., Rautenstrauss B. Transcriptional startpoints and methylation patterns in the PMP22 promoters of peripheral nerve, leukocytes and tumor cell lines. Int J Mol Med 2001, 7:669-675.
64. Huxley C., Passage E., Manson A., Putzu G., Figarella-Branger D., Pellissier J.F., Fontes M. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 1996, 5:563-569.
65. Huxley C., Passage E., Robertson A.M., Youl B., Huston S., Manson A., Saberan-Djoniedi D., Figarella-Branger D., Pellissier J.F., Thomas P.K., Fontes M. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 1998, 7:449-458.
66. Inoue K., Dewar K., Katsanis N., Reiter L.T., Lander E.S., Devon K.L., Wyman D.W., Lupski J.R., Birren B. The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes. Genome Res 2001, 11:1018-1033.
67. Ionasescu V.V., Searby C., Greenberg S.A. Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness: De novo dominant point mutation of the PMP22 gene. J Med Genet 1996, 33:1048-1049.
68. Ionasescu V.V., Searby C.C., Ionasescu R., Chatkupt S., Patel N., Koenigsberger R. Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene. Muscle Nerve 1997, 20:97-99.
69. Ionasescu V.V., Searby C.C., Ionasescu R., Reisin R., Ruggieri V., Arberas C. Severe Charcot-Marie-Tooth neuropathy type 1A with 1-base pair deletion and frameshift mutation in the peripheral myelin protein 22 gene. Muscle Nerve 1997, 20:1308-1310.
70. Jetten A.M., Suter U. The peripheral myelin protein 22 and epithelial membrane protein family. Prog Nucleic Acid Res Mol Biol 2000, 64:97-129.
71. Kamholz J., Shy M., Scherer S. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A [letter; comment]. Ann Neurol 1994, 36:451-452.
72. Kitamura K., Suzuki M., Uyemura K. Purification and partial characterization of two glycoproteins in bovine peripheral nerve myelin membrane. Biochim Biophys Acta 1976, 455:806-816.
73. Kitamura K., Uyemura K., Shibuya K., Sakamoto Y., Yoshimura K., Nomura M. Structure of a major oligosaccharide of PASII/PMP22 glycoprotein in bovine peripheral nerve myelin. J Neurochem 2000, 75:853-860.
74. Koenig H.L., Schumacher M., Ferzaz B., Thi A.N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y., Baulieu E.E. Progesterone synthesis and myelin formation by Schwann cells. Science 1995, 268:1500-1503.
75. Kovach M.J., Campbell K.C., Herman K., Waggoner B., Gelber D., Hughes L.F., Kimonis V.E. Anticipation in a unique family with Charcot-Marie-Tooth syndrome and deafness: Delineation of the clinical features and review of the literature. Am J Med Genet 2002, 108:295-303.
76. Kovach M.J., Lin J.P., Boyadjiev S., Campbell K., Mazzeo L., Herman K., Rimer L.A., Frank W., Llewellyn B., Wang Jabs E., et al. A unique point mutation in the PMP22 gene is associated with Charcot-Marie-Tooth disease and deafness. Am J Hum Genet 1999, 64:1580-1593.
77. Kuhn G., Lie A., Wilms S., Muller H.W. Coexpression of PMP22 gene with MBP and P0 during de novo myelination and nerve repair. Glia 1993, 8:256-264.
78. Lenssen P.P., Gabreels-Festen A.A., Valentijn L.J., Jongen P.J., van Beersum S.E., van Engelen B.G., van Wensen P.J., Bolhuis P.A., Gabreels F.J., Mariman E.C. Hereditary neuropathy with liability to pressure palsies. Phenotypic differences between patients with the common deletion and a PMP22 frame shift mutation. Brain 1998, 121:1451-1458.
79. Liehr T., Rautenstrauss B. Regional localization of rat peripheral myelin protein 22 (Pmp22) gene to chromosome 10q22 by FISH. Mamm Genome 1995, 6:489.
80. Lobsiger C.S., Magyar J.P., Taylor V., Wulf P., Welcher A.A., Program A.E., Suter U. Identification and characterization of a cDNA and the structural gene encoding the mouse epithelial membrane protein-1. Genomics 1996, 36:379-387.
81. Lupski J.R. Recessive Charcot-Marie-tooth disease. Ann Neurol 2000, 47:6-8.
82. Lupski J.R., de Oca Luna R.M., Slaugenhaupt S., Pentao L., Guzzetta V., Trask B.J., Saucedo-Cardenas O., Barker D.F., Killian J.M., Garcia C.A., et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991, 66:219-232.
83. Magyar J.P., Martini R., Ruelicke T., Aguzzi A., Adlkofer K., Dembic Z., Zielasek J., Toyka K.V., Suter U. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 1996, 16:5351-5360.
84. Maier M., Berger P., Nave K.A., Suter U. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves. Mol Cell Neurosci 2002, 20:93-109.
85. Maier M., Berger P., Suter U. Understanding Schwann cell-neurone interactions: The key to Charcot-Marie-Tooth disease?. J Anat 2002, 200:357-366.
86. Manfioletti G., Ruaro M.E., Del Sal G., Philipson L., Schneider C. A growth arrest-specific (gas) gene codes for a membrane protein. Mol Cell Biol 1990, 10:2924-2930.
87. Marques W., Thomas P.K., Sweeney M.G., Carr L., Wood N.W. Dejerine-Sottas neuropathy and PMP22 point mutations: A new base pair substitution and a possible "hot spot" on Ser72. Ann Neurol 1998, 43:680-683.
88. Matsunami N., Smith B., Ballard L., Lensch M.W., Robertson M., Albertsen H., Hanemann C.O., Muller H.W., Bird T.D., White R., Chance P.F. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet 1992, 1:176-179.
89. McLeod J.G., Low P.A. Animal models of peripheral neuropathy: The Trembler mouse. Muscle Nerve 1979, 2:495-502.
90. Melcangi R.C., Magnaghi V., Galbiati M., Ghelarducci B., Sebastiani L., Martini L. The action of steroid hormones on peripheral myelin proteins: A possible new tool for the rebuilding of myelin?. J Neurocytol 2000, 29:327-339.
91. Meuleman J., Pou-Serradell A., Lofgren A., Ceuterick C., Martin J.J., Timmerman V., Van Broeckhoven C., De Jonghe P. A novel 3'-splice site mutation in peripheral myelin protein 22 causing hereditary neuropathy with liability to pressure palsies. Neuromuscul Disord 2001, 11:400-403.
92. Mostacciuolo M.L., Righetti E., Zortea M., Bosello V., Schiavon F., Vallo L., Merlini L., Siciliano G., Fabrizi G.M., Rizzuto N., et al. Charcot-Marie-Tooth disease type I and related demyelinating neuropathies: Mutation analysis in a large cohort of Italian families. Hum Mutat 2001, 18:32-41.
93. Muller H.W. Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: New facts and hypotheses. Glia 2000, 29:182-185.
94. Naef R., Adlkofer K., Lescher B., Suter U. Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol Cell Neurosci 1997, 9:13-25.
95. Naef R., Suter U. Many facets of the peripheral myelin protein PMP22 in myelination and disease. Microsc Res Tech 1998, 41:359-371.
96. Naef R., Suter U. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol Dis 1999, 6:1-14.
97. Nelis E., Holmberg B., Adolfsson R., Holmgren G., van Broeckhoven C. PMP22 Thr(118)Met: Recessive CMT1 mutation or polymorphism?. Nat Genet 1997, 15:13-14.
98. Nelis E., Timmerman V., De Jonghe P., Van Broeckhoven C. Identification of a 5' splice site mutation in the PMP-22 gene in autosomal dominant Charcot-Marie-Tooth disease type 1. Hum Mol Genet 1994, 3:515-516.
99. Nelis E., Van Broeckhoven C., Consortium C. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: A european collaborative study. Eur J Hum Genet 1996, 4:25-33.
100. Neuberg D.H., Sancho S., Suter U. Altered molecular architecture of peripheral nerves in mice lacking the peripheral myelin protein 22 or connexin32. J Neurosci Res 1999, 58:612-623.
101. Nicholson G.A., Valentijn L.J., Cherryson A.K., Kennerson M.L., Bragg T.L., DeKroon R.M., Ross D.A., Pollard J.D., McLeod J.G., Bolhuis P.A., et al. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat Genet 1994, 6:263-266.
102. Niemann S., Sereda M.W., Suter U., Griffiths I.R., Nave K.A. Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22. J Neurosci 2000, 20:4120-4128.
103. Norreel J.C., Jamon M., Riviere G., Passage E., Fontes M., Clarac F. Behavioural profiling of a murine Charcot-Marie-Tooth disease type 1A model. Eur J Neurosci 2001, 13:1625-1634.
104. Notterpek L., Ryan M.C., Tobler A.R., Shooter E.M. PMP22 accumulation in aggresomes: Implications for CMT1A pathology. Neurobiol Dis 1999, 6:450-460.
105. Notterpek L., Shooter E.M., Snipes G.J. Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy. J Neurosci 1997, 17:4190-4200.
106. Notterpek L., Snipes G.J., Shooter E.M. Temporal expression pattern of peripheral myelin protein 22 during in vivo and in vitro myelination. Glia 1999, 25:358-369.
107. Notterpek L., Roux K.J., Amici S.A., Yazdanpour A., Rahner C., Fletcher B.S. Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia. Proc Natl Acad Sci USA 2001, 98:14404-14409.
108. Numakura C., Lin C., Oka N., Akiguchi I., Hayasaka K. Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot-Marie-Tooth disease type 1. Ann Neurol 2000, 47:101-103.
109. Ohnishi A., Yoshimura T., Kanehisa Y., Fukushima Y. A case of hereditary motor and sensory neuropathy type I with a new type of peripheral myelin protein (PMP)-22 mutation. Rinsho Shinkeigaku 1995, 35:788-792.
110. Paratore P., Hagedorn L., Floris J., Hari L., Kleber M., Suter U., Sommer L. Cell-intrinsic and cell-extrinsic cues regulating lineage decisions in multipotent neural crest-derived progenitor cells. Int J Dev Biol 2002, 46:193-200.
111. Pareek S., Notterpek L., Snipes G.J., Naef R., Sossin W., Laliberte J., Iacampo S., Suter U., Shooter E.M., Murphy R.A. Neurons promote the translocation of peripheral myelin protein 22 into myelin. J Neurosci 1997, 17:7754-7762.
112. Pareek S., Suter U., Snipes G.J., Welcher A.A., Shooter E.M., Murphy R.A. Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells. J Biol Chem 1993, 268:10372-10379.
113. Pareyson D., Taroni F. Deletion of the PMP22 gene and hereditary neuropathy with liability to pressure palsies. Curr Opin Neurol 1996, 9:348-354.
114. Parman Y., Plante-Bordeneuve V., Guiochon-Mantel A., Eraksoy M., Said G. Recessive inheritance of a new point mutation of the PMP22 gene in Dejerine-Sottas disease. Ann Neurol 1999, 45:518-522.
115. Parmantier E., Braun C., Thomas J.L., Peyron F., Martinez S., Zalc B. PMP-22 expression in the central nervous system of the embryonic mouse defines potential transverse segments and longitudinal columns. J Comp Neurol 1997, 378:159-172.
116. Parmantier E., Cabon F., Braun C., D'Urso D., Muller H.W., Zalc B. Peripheral myelin protein-22 is expressed in rat and mouse brain and spinal cord motoneurons. Eur J Neurosci 1995, 7:1080-1088.
117. Patel P.I., Roa B.B., Welcher A.A., Schoener-Scott R., Trask B.J., Pentao L., Snipes G.J., Garcia C.A., Francke U., Shooter E.M., et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992, 1:159-165.
118. Pentao L., Wise C.A., Chinault A.C., Patel P.I., Lupski J.R. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat Genet 1992, 2:292-300.
119. Perea J., Robertson A., Tolmachova T., Muddle J., King R.H., Ponsford S., Thomas P.K., Huxley C. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 2001, 10:1007-1018.
120. Raeymaekers P., Timmerman V., De Jonghe P., Swerts L., Gheuens J., Martin J.J., Muylle L., De Winter G., Vandenberghe A., Van Broeckhoven C. Localization of the mutation in an extended family with Charcot-Marie-Tooth neuropathy (HMSN I). Am J Hum Genet 1989, 45:953-958.
121. Raeymaekers P., Timmerman V., Nelis E., De Jonghe P., Hoogendijk J.E., Baas F., Barker D.F., Martin J.J., De Visser M., Bolhuis P.A., Van Broeckhoven C. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord 1991, 1:93-97.
122. Reiter L.T., Murakami T., Koeuth T., Pentao L., Muzny D.M., Gibbs R.A., Lupski J.R. A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet 1996, 12:288-297.
123. Roa B.B., Garcia C.A., Pentao L., Killian J.M., Trask B.J., Suter U., Snipes G.J., Ortiz-Lopez R., Shooter E.M., Patel P.I., et al. Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A. Nat Genet 1993, 5:189-194.
124. Roa B.B., Garcia C.A., Suter U., Kulpa D.A., Wise C.A., Mueller J., Welcher A.A., Snipes G.J., Shooter E.M., Patel P.I., et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993, 329:96-101.
125. Robertson A., Perea J., Tolmachova T., Thomas P.K., Huxley C. Effects of mouse strain, position of integration and tetracycline analogue on the tetracycline conditional system in transgenic mice. Gene 2002, 282:65-74.
126. Ryan M.C., Notterpek L., Tobler A.R., Liu N., Shooter E.M. Role of the peripheral myelin protein 22 N-linked glycan in oligomer stability. J Neurochem 2000, 75:1465-1474.
127. Ryan M.C., Shooter E.M., Notterpek L. Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiol Dis 2002, 10:109-118.
128. Saberan-Djoneidi D., Sanguedolce V., Assouline Z., Levy N., Passage E., Fontes M. Molecular dissection of the Schwann cell specific promoter of the PMP22 gene. Gene 2000, 248:223-231.
129. Sahenk Z., Chen L., Freimer M. A novel PMP22 point mutation causing HNPP phenotype: Studies on nerve xenografts. Neurology 1998, 51:702-707.
130. Sancho S., Magyar J.P., Aguzzi A., Suter U. Distal axonopathy in peripheral nerves of PMP22-mutant mice. Brain 1999, 122:1563-1577.
131. Sancho S., Young P., Suter U. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A. Brain 2001, 124:2177-2187.
132. Sanders C.R., Ismail-Beigi F., McEnery M.W. Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins. Biochemistry 2001, 40:9453-9459.
133. Schachner M., Martini R. Glycans and the modulation of neural-recognition molecule function. Trends Neurosci. 1995, 18:183-191.
134. Schenone A., Nobbio L., Caponnetto C., Abbruzzese M., Mandich P., Bellone E., Ajmar F., Gherardi G., Windebank A.J., Mancardi G. Correlation between PMP-22 messenger RNA expression and phenotype in hereditary neuropathy with liability to pressure palsies. Ann Neurol 1997, 42:866-872.
135. Schenone A., Nobbio L., Mandich P., Bellone E., Abbruzzese M., Aymar F., Mancardi G.L., Windebank A.J. Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies. Neurology 1997, 48:445-449.
136. Scherer S.S. The biology and pathobiology of Schwann cells. Curr Opin Neurol 1997, 10:386-397.
137. Schneider C., King R.M., Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell 1988, 54:787-793.
138. Sedzik J., Kotake Y., Uyemura K. Purification of PASII/PMP22-an extremely hydrophobic glycoprotein of PNS myelin membrane. Neuroreport 1998, 9:1595-1600.
139. Sedzik J., Tsukihara T. Solubilization of PNS myelin membrane proteins by detergents. Neuroreport 2000, 11:2559-2563.
140. Seeman P., Mazanec R., Marikova T., Rautenstrauss B. Charcot-Marie-Tooth 1A: Heterozygous T118M mutation over a CMT1A duplication has no influence on the phenotype. Ann NY Acad Sci 1999, 883:485-489.
141. Sereda M., Griffiths I., Puhlhofer A., Stewart H., Rossner M.J., Zimmerman F., Magyar J.P., Schneider A., Hund E., Meinck H.M., et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 1996, 16:1049-1060.
142. Shapiro L., Doyle J.P., Hensley P., Colman D.R., Hendrickson W.A. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 1996, 17:435-449.
143. Shugart E.C., Levenson A.S., Constance C.M., Umek R.M. Differential expression of gas and gadd genes at distinct growth arrest points during adipocyte development. Cell Growth Differ 1995, 6:1541-1547.
144. Simonati A., Fabrizi G.M., Pasquinelli A., Taioli F., Cavallaro T., Morbin M., Marcon G., Papini M., Rizzuto N. Congenital hypomyelination neuropathy with Ser72Leu substitution in PMP22. Neuromuscul Disord 1999, 9:257-261.
145. Snipes G.J., Suter U. Molecular anatomy and genetics of myelin proteins in the peripheral nervous system. J Anat 1995, 186:483-494.
146. Snipes G.J., Suter U. Molecular basis of common hereditary motor and sensory neuropathies in humans and in mouse models. Brain Pathol 1995, 5:233-247.
147. Snipes G.J., Suter U., Shooter E.M. Human peripheral myelin protein-22 carries the L2/HNK-1 carbohydrate adhesion epitope. J Neurochem 1993, 61:1961-1964.
148. Snipes G.J., Suter U., Welcher A.A., Shooter E.M. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 1992, 117:225-238.
149. Spreyer P., Kuhn G., Hanemann C.O., Gillen C., Schaal H., Kuhn R., Lemke G., Muller H.W. Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth arrest-specific' gene. Embo J 1991, 10:3661-3668.
150. Stoffel W., Bosio A. Myelin glycolipids and their functions. Curr Opin Neurobiol 1997, 7:654-661.
151. Suter U. Charcot-Marie-Tooth disease. Pathology, genetics and animal models. Mouse Models of Human Neurological Diseases 1998, Plenum Press. B. Popko (Ed.).
152. Suter U., Moskow J.J., Welcher A.A., Snipes G.J., Kosaras B., Sidman R.L., Buchberg A.M., Shooter E.M. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci USA 1992, 89:4382-4386.
153. Suter U., Patel P.I. Genetic basis of inherited peripheral neuropathies. Hum Mutat 1994, 3:95-102.
154. Suter U., Snipes G.J. Biology and genetics of hereditary motor and sensory neuropathies. Ann Rev Neurosci 1995, 18:45-75.
155. Suter U., Snipes G.J., Schoener-Scott R., Welcher A.A., Pareek S., Lupski J.R., Murphy R.A., Shooter E.M., Patel P.I. Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem 1994, 269:25795-25808.
156. Suter U., Welcher A.A., Ozcelik T., Snipes G.J., Kosaras B., Francke U., Billings-Gagliardi S., Sidman R.L., Shooter E.M. Trembler mouse carries a point mutation in a myelin gene. Nature 1992, 356:241-244.
157. Suter U., Welcher A.A., Snipes G.J. Progress in the molecular understanding of hereditary peripheral neuropathies reveals new insights into the biology of the peripheral nervous system. Trends Neurosci 1993, 16:50-56.
158. Takeda Y., Notsu T., Kitamura K., Uyemura K. Functional analysis for peripheral myelin protein PASII/PMP22: Is it a member of claudin superfamily?. Neurochem Res 2001, 26:599-607.
159. Taylor V., Welcher A.A., Program A.E., Suter U. Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family. J Biol Chem 1995, 270:28824-28833.
160. Taylor V., Zgraggen C., Naef R., Suter U. Membrane topology of peripheral myelin protein 22. J Neurosci Res 2000, 62:15-27.
161. Thomas P.K., Marques W., Davis M.B., Sweeney M.G., King R.H., Bradley J.L., Muddle J.R., Tyson J., Malcolm S., Harding A.E. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 1997, 120:465-478.
162. Timmerman V., Nelis E., Van Hul W., Nieuwenhuijsen B.W., Chen K.L., Wang S., Ben Othman K., Cullen B., Leach R.J., Hanemann C.O., et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet 1992, 1:171-175.
163. Tiwari-Woodruff S.K., Buznikov A.G., Vu T.Q., Micevych P.E., Chen K., Kornblum H.I., Bronstein J.M. OSP/claudin-11 forms a complex with a novel member of the tetraspanin super family and beta1 integrin and regulates proliferation and migration of oligodendrocytes. J Cell Biol 2001, 153:295-305.
164. Tobler A.R., Liu N., Mueller L., Shooter E.M. Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22. Proc Natl Acad Sci USA 2002, 99:483-488.
165. Tobler A.R., Notterpek L., Naef R., Taylor V., Suter U., Shooter E.M. Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction. J Neurosci 1999, 19:2027-2036.
166. Tsukita S., Furuse M., Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001, 2:285-293.
167. Tyson J., Ellis D., Fairbrother U., King R.H., Muntoni F., Jacobs J., Malcolm S., Harding A.E., Thomas P.K. Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. Brain 1997, 120:47-63.
168. Valentijn L.J., Baas F., Wolterman R.A., Hoogendijk J.E., van den Bosch N.H., Zorn I., Gabreels-Festen A.W., de Visser M., Bolhuis P.A. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 1992, 2:288-291.
169. Valentijn L.J., Bolhuis P.A., Zorn I., Hoogendijk J.E., van den Bosch N., Hensels G.W., Stanton V.P., Housman D.E., Fischbeck K.H., Ross D.A., et al. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat Genet 1992, 1:166-170.
170. Vallat J.M., Sindou P., Preux P.M., Tabaraud F., Milor A.M., Couratier P., LeGuern E., Brice A. Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann. Neurol. 1996, 39:813-817.
171. Vance J.M., Nicholson G.A., Yamaoka L.H., Stajich J., Stewart C.S., Speer M.C., Hung W.Y., Roses A.D., Barker D., Pericak-Vance M.A. Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17. Exp Neurol 1989, 104:186-189.
172. Wang C.X., Wadehra M., Fisk B.C., Goodglick L., Braun J. Epithelial membrane protein 2, a 4-transmembrane protein that suppresses B-cell lymphoma tumorigenicity. Blood 2001, 97:3890-3895.
173. Welcher A.A., Suter U., De Leon M., Snipes G.J., Shooter E.M. A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc Natl Acad Sci USA 1991, 88:7195-7199.
174. Wilson H.L., Wilson S.A., Surprenant A., North R.A. Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C-terminus. J Biol Chem 2002, 277:34017-34023.
175. Windebank A.J. INherited recurrent neuropathy. Peripheral Neuropathy 1993, 1094-1136. WB Saunders, New York. P.J. Dyck, P.K. Thomas, J.W. Griffin, P.A. Low, J.F. Poduslo (Eds.).
176. Wise C.A., Garcia C.A., Davis S.N., Heju Z., Pentao L., Patel P.I., Lupski J.R. Molecular analysis of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMT1A duplication. Am J Hum Genet 1993, 53:853-863.
177. Wulf P., Bernhardt R.R., Suter U. Characterization of peripheral myelin protein 22 in zebrafish (zPMP22) suggests an early role in the development of the peripheral nervous system. J Neurosci Res 1999, 57:467-478.
178. Yener G.G., Guiochon-Mantel A., Obuz F., Baklan B., Ozturk V., Kovanlikaya I., Cakmur R., Gene A. Phe 84 deletion of the PMP22 gene associated with hereditary motor and sensory neuropathy HMSN III with multiple cranial neuropathy: Clinical, neurophysiological and magnetic resonance imaging findings. J Neurol 2001, 248:193-196.
179. Yoshikawa H., Nishimura T., Nakatsuji Y., Fujimura H., Himoro M., Hayasaka K., Sakoda S., Yanagihara T. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 1994, 35:445-450.
180. Young P., Stogbauer F., Eller B., de Jonghe P., Lofgren A., Timmerman V., Rautenstrauss B., Oexle K., Grehl H., Kuhlenbaumer G., et al. PMP22 Thr118Met is not a clinically relevant CMT1 marker. J Neurol 2000, 247:696-700.
181. Young P., Wiebusch H., Stogbauer F., Ringelstein B., Assmann G., Funke H. A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies. Neurology 1997, 48:450-452.
182. Zoidl G., Blass-Kampmann S., D'Urso D., Schmalenbach C., Muller H.W. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: Modulation of cell growth. Embo J 1995, 14:1122-1128.